These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 9022810)
21. Common and distinct mechanisms of different redox-active carcinogens involved in the transformation of mouse JB6P+ cells. Yang S; Misner B; Chiu R; Meyskens FL Mol Carcinog; 2008 Jul; 47(7):485-91. PubMed ID: 18092320 [TBL] [Abstract][Full Text] [Related]
22. Modulation of transcription factor AP-1 activity in murine EL-4 thymoma cells by vomitoxin (deoxynivalenol). Li S; Ouyang Y; Yang GH; Pestka JJ Toxicol Appl Pharmacol; 2000 Feb; 163(1):17-25. PubMed ID: 10662601 [TBL] [Abstract][Full Text] [Related]
23. Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells. Daschner PJ; Ciolino HP; Plouzek CA; Yeh GC Breast Cancer Res Treat; 1999 Feb; 53(3):229-40. PubMed ID: 10369069 [TBL] [Abstract][Full Text] [Related]
24. Activation of AP-1 in primary B lymphocytes by surface immunoglobulin requires de novo Jun-B synthesis. Tanguay DA; Dickinson JA; McManus BJ; Huo L; Rothstein TL; Chiles TC Cell Immunol; 1994 Oct; 158(2):281-91. PubMed ID: 7923384 [TBL] [Abstract][Full Text] [Related]
25. Role of AP-1 in ethanol-induced N-methyl-D-aspartate receptor 2B subunit gene up-regulation in mouse cortical neurons. Qiang M; Ticku MK J Neurochem; 2005 Dec; 95(5):1332-41. PubMed ID: 16313514 [TBL] [Abstract][Full Text] [Related]
26. B-ATF functions as a negative regulator of AP-1 mediated transcription and blocks cellular transformation by Ras and Fos. Echlin DR; Tae HJ; Mitin N; Taparowsky EJ Oncogene; 2000 Mar; 19(14):1752-63. PubMed ID: 10777209 [TBL] [Abstract][Full Text] [Related]
27. AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers. Suzukawa K; Colburn NH Oncogene; 2002 Mar; 21(14):2181-90. PubMed ID: 11948401 [TBL] [Abstract][Full Text] [Related]
28. Conversion of HPV 18 positive non-tumorigenic HeLa-fibroblast hybrids to invasive growth involves loss of TNF-alpha mediated repression of viral transcription and modification of the AP-1 transcription complex. Soto U; Das BC; Lengert M; Finzer P; zur Hausen H; Rösl F Oncogene; 1999 May; 18(21):3187-98. PubMed ID: 10359524 [TBL] [Abstract][Full Text] [Related]
29. Differentiation of mouse keratinocytes is accompanied by PKC-dependent changes in AP-1 proteins. Rutberg SE; Saez E; Glick A; Dlugosz AA; Spiegelman BM; Yuspa SH Oncogene; 1996 Jul; 13(1):167-76. PubMed ID: 8700543 [TBL] [Abstract][Full Text] [Related]
30. AP-1 activity during normal human keratinocyte differentiation: evidence for a cytosolic modulator of AP-1/DNA binding. Briata P; D'Anna F; Franzi AT; Gherzi R Exp Cell Res; 1993 Jan; 204(1):136-46. PubMed ID: 8416791 [TBL] [Abstract][Full Text] [Related]
31. Opposing activities of c-Fos and Fra-2 on AP-1 regulated transcriptional activity in mouse keratinocytes induced to differentiate by calcium and phorbol esters. Rutberg SE; Saez E; Lo S; Jang SI; Markova N; Spiegelman BM; Yuspa SH Oncogene; 1997 Sep; 15(11):1337-46. PubMed ID: 9315102 [TBL] [Abstract][Full Text] [Related]
32. AP-1 activation and altered AP-1 composition in association with increased phosphorylation and expression of specific Jun and Fos family proteins induced by vinblastine in KB-3 cells. Berry A; Goodwin M; Moran CL; Chambers TC Biochem Pharmacol; 2001 Sep; 62(5):581-91. PubMed ID: 11585055 [TBL] [Abstract][Full Text] [Related]
33. Hepatocyte growth factor activates the AP-1 complex: a comparison between normal and transformed rat hepatocytes. Rahmani M; Nadori F; Durand-Schneider AM; Lardeux B; Bernuau D J Hepatol; 1999 May; 30(5):916-25. PubMed ID: 10365821 [TBL] [Abstract][Full Text] [Related]
34. Parathyroid hormone versus phorbol ester stimulation of activator protein-1 gene family members in rat osteosarcoma cells. Koe RC; Clohisy JC; Tyson DR; Pulumati MR; Cook TF; Partridge NC Calcif Tissue Int; 1997 Jul; 61(1):52-8. PubMed ID: 9192514 [TBL] [Abstract][Full Text] [Related]
35. The effect of tumor necrosis factor-alpha and cAMP on induction of AP-1 activity in MA-10 tumor Leydig cells. Li X; Hales KH; Watanabe G; Lee RJ; Pestell RG; Hales DB Endocrine; 1997 Jun; 6(3):317-24. PubMed ID: 9368689 [TBL] [Abstract][Full Text] [Related]
36. Overexpression of JunB in undifferentiated malignant rat oral keratinocytes enhances the malignant phenotype in vitro without altering cellular differentiation. Robinson CM; Prime SS; Huntley S; Stone AM; Davies M; Eveson JW; Paterson IC Int J Cancer; 2001 Mar; 91(5):625-30. PubMed ID: 11267971 [TBL] [Abstract][Full Text] [Related]
37. Regulation of human thioltransferase (hTTase) gene by AP-1 transcription factor under oxidative stress. Krysan K; Lou MF Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1876-83. PubMed ID: 12036993 [TBL] [Abstract][Full Text] [Related]
38. Activation of AP-1 and of a nuclear redox factor, Ref-1, in the response of HT29 colon cancer cells to hypoxia. Yao KS; Xanthoudakis S; Curran T; O'Dwyer PJ Mol Cell Biol; 1994 Sep; 14(9):5997-6003. PubMed ID: 8065332 [TBL] [Abstract][Full Text] [Related]
39. The v-Jun oncoprotein replaces p39 c-Jun as the predominant AP-1 constituent in ASV17-transformed fibroblasts: implications for SAPK/JNK-mediated signal transduction. Kilbey A; Black EJ; Unlu M; Gillespie DA Oncogene; 1996 Jun; 12(11):2409-18. PubMed ID: 8649782 [TBL] [Abstract][Full Text] [Related]